[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1961

Experimental Atherosclerosis and Portacaval Shunt

Author Affiliations

NEW YORK
From the Department of Surgery, Columbia University, College of Physicians and Surgeons.

Arch Surg. 1961;82(1):66-68. doi:10.1001/archsurg.1961.01300070070009
Abstract

The role of the liver in cholesterol metabolism and experimental atherogenesis is not completely understood. Katz and Stamler1 in their familiar monograph on "Experimental Atherosclerosis" state that, to their knowledge, "no thorough-going studies have been carried out on the influence of hepatic factors on atherogenesis in experimental animals." According to the texts, free cholesterol exists in the blood stream as a result of the breakdown of erythrocytes and other cells and is excreted by the liver in bile—the only body fluid in which it is readily soluble. In addition, the liver may synthesize cholesterol from acetate by a process involving some 26 separate enzymatic reactions. According to Siperstein and Guest,2 exogenous cholesterol may exert some control over this synthesis by a feedback mechanism probably blocking the synthesis prior to the formation of squalene. Little else appears to be known of the handling of exogenous cholesterol by the liver.

First Page Preview View Large
First page PDF preview
First page PDF preview
×